(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AMYLOSCAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

AMYLOSCAN

ST13

US500000088872459

Class

9, 16, 44

Filing

88872459

Registration

6727080

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

01/17/2025

Trademark type

Combined

Nice classes

9, 16, 44

Filing date

04/15/2020

Registration date

05/24/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/24/2022

Last transaction

01/17/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

5

Owner type

99

Owner location

Kiel, DE

Examiner

COWARD, JEFFERY

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "AMYLOSCAN" with both the letters "A" and "S" capitalized, the letters "AMYLO" bolder than the letters "SCAN" and the letter "Y" being larger than the remaining letters and having a small circular accent.

Holders and representatives

Holders

U. S. (pessoa física)

Representatives

Nicholas Spencer Whitelaw Jordan IP Law, LLC

Technical classification

Nice Classes

Class 9Class 16Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable and recorded computer software in the nature of diagnosis guidelines and patient questionnaires stored on data carriers for disease diagnosis and assessment in the field of amyloidosis

Class 16

Printed matterprinted diagnosis guidelines and patient questionnaires for disease diagnosis and assessment in the field of amyloidosis

Class 44

Medical servicesproviding medical consultancy and information for purposes of disease diagnosis and assessment in the field of amyloidosis

Publications

History of USPTO decisions and trademark events.

27 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/16/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/16/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/16/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/24/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/24/2022

CHPB

POST PUBLICATION AMENDMENT - ENTERED

08/30/2021

APET

ASSIGNED TO PETITION STAFF

08/27/2021

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

08/25/2021

CHPN

POST PUBLICATION AMENDMENT – NOT ENTERED

05/25/2021

APET

ASSIGNED TO PETITION STAFF

05/21/2021

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

03/17/2021

ISPO

WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST

03/12/2021

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

03/10/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/26/2021

PUBO

PUBLISHED FOR OPPOSITION

01/26/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/06/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/21/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/15/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/15/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/05/2020

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

06/12/2020

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

06/12/2020

EPEN

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

06/12/2020

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

06/12/2020

DOCK

ASSIGNED TO EXAMINER

06/08/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/24/2020

NWAP

NEW APPLICATION ENTERED

04/18/2020

Continuous trademark protection

Get notified about every new filing that threatens AMYLOSCAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.